What is DeciBio?
DeciBio operates at the intersection of precision medicine strategy, data, and analytics. The company provides critical market intelligence and consulting partnerships to a diverse clientele spanning clinical diagnostics, financial services, pharmaceuticals, biotechnology, and research tools. Their comprehensive service offerings include in-depth market research, competitive analysis, strategic consulting, and advanced data analytics, all designed to accelerate innovation within the precision medicine ecosystem. DeciBio is committed to navigating market developments and supporting clients through every stage, from early-stage research to full commercialization.
How much funding has DeciBio raised?
DeciBio has raised a total of $850K across 2 funding rounds:
Debt
$350K
Debt
$500K
Debt (2020): $350K with participation from PPP
Debt (2024): $500K, investors not publicly disclosed
What's next for DeciBio?
The recent major strategic investment signifies a strong vote of confidence in DeciBio's business model and its capacity for future growth. This capital infusion is expected to fuel further expansion of its data analytics capabilities and strategic consulting services, enabling DeciBio to deepen its market penetration and enhance its support for clients navigating the complex precision medicine landscape. The company is well-positioned to capitalize on emerging trends and solidify its leadership in providing essential intelligence for innovation and commercialization.
See full DeciBio company page
